| Literature DB >> 30037126 |
Ruth Walker1, Christie Bennett2, Michelle Blumfield3, Stella Gwini4, Jianhua Ma5, Fenglei Wang6, Yi Wan7, Helen Truby8.
Abstract
Excessive maternal gestational weight gain (GWG) contributes to generational obesity. Our aim was to explore efficacy and intervention characteristics (trimester, duration, frequency, intensity, and delivery method) of interventions to prevent excessive GWG. CINAHL, Cochrane, EMBASE, LILACS, MEDLINE, PsycINFO, and Scopus were searched up to May 2018 (no date or language restrictions). Keywords and MeSH terms for diet, GWG, intervention, lifestyle, maternal, physical activity, and pregnancy were used to locate randomized-controlled trials (RCTs). The Cochrane Collaboration tool for assessing risk of bias was applied. Eighty-nine RCTs were included. Meta-analysis (60 trials) estimated that women in diet only (WMD: -3.27; 95% CI: -4.96, -1.58, p < 0.01), physical activity (PA) (WMD: -1.02; 95% CI: -1.56, -0.49, p < 0.01), and lifestyle interventions (combining diet and PA) (WMD: -0.84; 95% CI: -1.29, -0.39, p < 0.01) gained significantly less weight than controls. The three eHealth interventions favored neither intervention nor control (WMD: -1.06; 95% CI: -4.13, 2.00, p = 0.50). Meta-regression demonstrated no optimal duration, frequency, intensity, setting, or diet type. Traditional face to face delivery of weight management interventions during pregnancy can be successful. Delivery via eHealth has potential to extend its reach to younger women but needs further evaluation of its success.Entities:
Keywords: diet; gestational weight gain; interventions; lifestyle; maternal; physical activity; pregnancy
Mesh:
Year: 2018 PMID: 30037126 PMCID: PMC6073617 DOI: 10.3390/nu10070944
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1PRISMA flowchart of study selection.
Random-effects meta-analyses for diet, physical activity, lifestyle, and eHealth interventions (WMD and 95% CI). (Figures of meta-analyses are Supplementary Figures S1–S4).
| Sub-Group and Overall | Studies a | Participants | Overall Effect Size |
| ||
|---|---|---|---|---|---|---|
| Diet | Overall: Measurement GWG > 24 weeks | 9 | 2049 | −3.27 (−4.96, −1.58) | <0.00 | 92.8% |
| Physical activity | Measurement GWG 12–24 weeks | 3 | 250 | −0.83 (−3.55, 1.90) | 0.55 | 83.3% |
| Measurement GWG > 24 weeks | 21 | 4651 | −1.02 (−1.56, −0.47) | <0.00 | 81.8% | |
| Overall | 24 | 4901 | −1.02 (−1.56, −0.49) | <0.00 | 81.9% | |
| Lifestyle | Measurement GWG 12–24 weeks | 5 | 2908 | −0.67 (−1.58, 0.23) | 0.14 | 80.1% |
| Measurement GWG > 24 weeks | 19 | 4471 | −0.92 (−1.48, −0.36) | <0.00 | 69.8% | |
| Overall | 24 | 7379 | −0.84 (−1.29, −0.39) | <0.00 | 71.0% | |
| eHealth | Overall: Measurement GWG > 24 weeks | 3 | 192 | −1.06 (−4.13, 2.00) | 0.50 | 73.6% |
a Some studies included sub-groups as no overall GWG was reported.
Meta-regression of characteristics of diet and lifestyle interventions designed to prevent excessive GWG.
| Diet (10 Observations) | PA (25 Observations) | Lifestyle (27 Observations) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | ß | 95% CI |
| ß | 95% CI |
| ß | 95% CI |
| |||
|
|
|
|
| |||||||||
| 1 | 3 | Ref | 12 | Ref | 6 | Ref | ||||||
| 2 | 6 | 0.35 | −4.61, 5.32 | 0.87 | 13 | 0.81 | −0.13, 1.75 | 0.09 | 21 | −0.16 | −1.50, 1.17 | 0.81 |
| 3 | 0 | NA | NA | NA | 0 | NA | NA | NA | 0 | NA | NA | NA |
|
|
|
|
| |||||||||
| 1–4 h | 5 | Ref | 5 | Ref | 8 | Ref | ||||||
| >4–8 h | 2 | −1.08 | −7.43, 5.28 | 0.70 | 1 | 1.50 | −2.77, 5.77 | 0.47 | 7 | 0.00 | −1.46, 1.46 | 1.00 |
| ≥8 times | 3 | 0.71 | −5.04, 6.46 | 0.78 | 19 | 0.05 | −1.37, 1.48 | 0.94 | 8 | −1.32 | −2.71, 0.08 | 0.06 |
|
|
|
|
| |||||||||
| 1–3 times | 5 | Ref | 3 | Ref | 3 | Ref | ||||||
| 4–7 times | 1 | −1.92 | −10.18, 6.33 | 0.60 | 2 | 0.55 | −2.71, 3.81 | 0.73 | 10 | 0.18 | −1.79, 2.14 | 0.86 |
| ≥8 times | 4 | 0.46 | −4.73, 5.65 | 0.84 | 20 | 0.02 | −1.94, 1.98 | 0.99 | 17 | −0.04 | −1.95, 1.88 | 0.97 |
|
|
|
|
| |||||||||
| Individual | 9 | Ref | 7 | Ref | 19 | Ref | ||||||
| Group | 0 | NA | NA | NA | 11 | −0.62 | −1.56, 0.31 | 0.18 | 8 | −1.09 | −2.28, 0.09 | 0.07 |
| Mixed | 1 | 2.01 | −5.17, 9.20 | 0.54 | 2 | −1.99 | −3.45, −0.52 | 0.01 | 0 | NA | NA | NA |
|
|
|
|
| |||||||||
| Reference | Ref | Ref | Ref | |||||||||
| −0.65 | −1.81, 0.52 | 0.23 | 0.01 | −0.09, 0.10 | 0.90 | −0.04 | −0.12, 0.04 | 0.34 | ||||
|
|
| |||||||||||
| General | 3 | Ref | ||||||||||
| Low-GI | 1 | −0.06 | −8.59, 8.48 | 0.99 | ||||||||
| kJ restriction | 5 | −3.20 | −8.81, 2.42 | 0.21 | ||||||||
| Probiotic | 1 | −2.56 | −11.32, 6.21 | 0.50 | ||||||||
Note: Observations, not studies (some studies were analyzed as sub-groups). Characteristics unknown for some studies. Abbreviations: NA = none of the studies in that intervention type displayed this characteristic. Ref: Reference group.
Summary of the effectiveness of interventions according to characteristics.
| Effective, | Ineffective, | Total a
| |||
|---|---|---|---|---|---|
|
| |||||
|
| |||||
|
| 12 (41.4) | 17 (58.6) | 29 | 0.73 | |
|
| 18 (45.0) | 22 (55.0) | 40 | 0.83 | |
|
| 0 (0.0) | 0 (0.0) | 0 | - | |
|
| 2 (50.0) | 2 (50.0) | 4 | 0.80 | |
|
| |||||
|
| |||||
|
| 2 (66.7) | 1 (33.3) | 3 | 0.42 | |
|
| 21 (40.4) | 31 (59.6) | 52 | 0.35 | |
|
| 7 (50.0) | 7 (50.0) | 14 | 0.61 | |
|
| 2 (50.0) | 2 (50.0) | 4 | 0.80 | |
|
| |||||
|
| |||||
|
| 6 (33.3) | 12 (66.7) | 18 | 0.30 | |
|
| 3 (37.5) | 5 (62.5) | 8 | 0.70 | |
|
| 14 (43.8) | 18 (56.3) | 32 | 0.99 | |
|
| 9 (60.0) | 6 (40.0) | 15 | 0.16 | |
|
| |||||
|
| |||||
|
| 4 (33.3) | 8 (66.7) | 12 | 0.42 | |
|
| 4 (30.8) | 9 (69.2) | 13 | 0.30 | |
|
| 19 (47.5) | 21 (52.5) | 40 | 0.49 | |
|
| 5 (62.5) | 3 (37.5) | 8 | 0.26 | |
|
| |||||
|
| 14 (33.3) | 28 (66.7) | 42 | 0.04 | |
|
| 15 (62.5) | 9 (37.5) | 24 | 0.02 | |
|
| 3 (42.9) | 4 (51.7) | 7 | 0.96 |
a No overall p value (or differing significance for sub-groups) and no control. b Combining interventions that involve group delivery and a combination of individual and group delivery.
Figure 2Risk of bias assessed using the Cochrane collaboration tool for assessing risk of bias.